MIRUM PHARMACEUTICALS INC's ticker is MIRM and the CUSIP is 604749101. A total of 100 filers reported holding MIRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $222 | -99.9% | 6,503 | -56.3% | 0.02% | -63.6% |
| Q1 2022 | $327,000 | -11.1% | 14,869 | -35.6% | 0.04% | -4.3% |
| Q4 2021 | $368,000 | -53.5% | 23,101 | -41.8% | 0.05% | -43.2% |
| Q3 2021 | $791,000 | +45.1% | 39,708 | +26.0% | 0.08% | +32.8% |
| Q2 2021 | $545,000 | -21.1% | 31,515 | -9.6% | 0.06% | -47.0% |
| Q1 2021 | $691,000 | +82.3% | 34,859 | +60.6% | 0.12% | +85.5% |
| Q4 2020 | $379,000 | – | 21,709 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 6,495,392 | $222,077,452 | 10.39% |
| BOONE CAPITAL MANAGEMENT LLC | 523,679 | $17,904,585 | 4.67% |
| TANG CAPITAL MANAGEMENT LLC | 1,287,107 | $44,006,188 | 4.48% |
| BVF INC/IL | 4,370,024 | $149,411,121 | 4.19% |
| First Turn Management, LLC | 703,398 | $24,049,178 | 3.91% |
| Nan Fung Group Holdings Ltd | 106,100 | $3,627,559 | 3.87% |
| Prosight Management, LP | 314,800 | $10,763,012 | 3.22% |
| Novo Holdings A/S | 1,500,000 | $51,285,000 | 2.98% |
| Lion Point Capital, LP | 45,000 | $1,538,550 | 2.80% |
| Highlander Partners, L.P. | 122,980 | $4,204,686 | 2.80% |